SCHEMBL5215134

SCHEMBL5215134

CCc1nc(-c2ccc(C(F)(F)F)cc2)oc1C(C)O

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HEXA P06865 1/20 0.43
HEXB P07686 1/20 0.43
IKBKB O14920 1/20 0.42
PPARG P37231 5/20 0.41
PPARA Q07869 5/20 0.41
PPARD Q03181 5/20 0.41
TRPV3 Q8NET8 3/20 0.39
PTPN1 P18031 2/20 0.39
UTRN P46939 1/20 0.38
LMNA P02545 1/20 0.38
THRB P10828 1/20 0.38
NOTUM Q6P988 1/20 0.38
KDM4E B2RXH2 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP1A2 P05177 1/20 0.37
POLB P06746 1/20 0.37
CYP2C19 P33261 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4464845 0.82 PPARD (0.48) IKBKBPPARGPPARAPPARDPTPN1
SCHEMBL4475310 0.81 IKBKB (0.44) IKBKBPPARGPPARAPPARDTRPV3
SCHEMBL4464968 0.80 IKBKB (0.43) IKBKBPPARGPPARAPPARDPTPN1
SCHEMBL18003565 0.80 IKBKB (0.43) IKBKBPPARGPPARAPPARDTRPV3
SCHEMBL20861471 0.79 PPARA (0.53) HEXAHEXBIKBKBPPARGPPARA
SCHEMBL4476959 0.78 PPARG (0.45) HEXAHEXBIKBKBPPARGPPARA
SCHEMBL3982662 0.77 LMNA (0.42) IKBKBPPARGPPARAPPARDTRPV3
SCHEMBL4468865 0.76 PPARD (0.48) IKBKBPPARGPPARAPPARDPTPN1
SCHEMBL4468828 0.74 PPARD (0.46) IKBKBPPARGPPARAPPARDPTPN1
SCHEMBL5217188 0.74 HEXA (0.44) HEXAHEXBIKBKBPPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1480640-B1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS LILLY CO ELI (US) 2007-08-15 EP disclosed
EP-1480640-B1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS LILLY CO ELI (US) 2007-08-15 EP disclosed
US-7153878-B2 Peroxisome proliferator activated receptor modulators ELI LILLY AND COMPANY (US) 2006-12-26 US disclosed
US-20050107449-A1 Peroxisome proliferator activated receptor modulators ELILILLY AND COMPANY 2005-05-19 US disclosed
EP-1480640-A1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2004-12-01 EP disclosed
WO-2003072100-A1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2003-09-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107449-A1 Peroxisome proliferator activated receptor modulators PPARG, PPARA, PPARD HEXA 4089/4885HEXB 3227/4885IKBKB 4269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.